KDM5B and breast cancer: Consistent with this, we found that the mRNA expression level of KDM5B was slightly higher in the HER2+ subtype, compared with luminal and basal-like subtypes, in both TCGA and METABRIC breast cancer samples (Supplementary Figure S3).